Results 51 to 60 of about 374 (131)

Response to Does Pseudoresistant Hypertension Attributed to White-Coat Effect Define Subjects With “Treated Normalized Hypertension?” [PDF]

Hypertension, 2012
Franklin et al1 prefer to describe treated hypertensive patients with a high office systolic blood pressure (BP) and normal daytime ambulatory systolic BP as having “treated normalized hypertension” instead of the term proposed in the editorial, “pseudoresistant hypertension because of white coat effect.” Franklin et al1 believe that pseudoresistant ...
openaire   +1 more source

Pseudoresistance in patients with epilepsy--characteristics and determining factors.

Folia medica, 2009
In pseudorefractory epilepsy (20% of the cases diagnosed with refractory epilepsy) the factors responsible for triggering the seizures are extraneous to epilepsy and the seizures can be controlled after diagnostic and therapeutic re-evaluation.To determine the factors causing development of pseudoresistance in patients with epilepsy.Detailed case ...
Ekaterina I, Viteva, Zahari I, Zahariev
openaire   +1 more source

Hipertensão pseudo-resistente causada por baixa adesão terapêutica

Revista de Ciências Farmacêuticas Básica e Aplicada, 2015
Este estudo teve como objetivo identificar pacientes com hipertensão arterial pseudo-resistente causada pela não-adesão terapêutica. Foi realizado um estudo transversal com pacientes com hipertensão atendidos pela Estratégia de Saúde da Família.
Alfredo Dias Oliveira-Filho, Anna Karla Cesar Leandro, Mirela Quirino Almeida, Divaldo Pereira Lyra Junior, Sabrina Joany Felizardo Neves   +4 more
doaj  

Pseudo-resistance to anticancer drugs

Therapeutic Advances in Medical Oncology, 2022
Enrico Davoli, Massimo Zucchetti, Raffaella Giavazzi, Silvio Garattini, Roberta Frapolli   +4 more
doaj   +1 more source

PseudoResistance DB: A new Database of antibiotics related to Pseudomonas aeruginosa antibiotic resistance

Latin American Data in Science
Antibiotic resistance represents a significant challenge to global health, compromising the effectiveness of treatments. Pseudomonas aeruginosa, an opportunistic Gram-negative bacterium, is a priority pathogenic agent for research, being categorized as critical level by the World Health Organization (WHO) for the development of new therapeutic ...
Caio Bessa Nunes, Vinnícius Machado Schelk Gomes, Caio Felipe de Araujo Ribas Cheohen, Manuela Leal Da Silva   +3 more
openaire   +1 more source

Role of home blood pressure monitoring in resistant hypertension. [PDF]

Clin Hypertens, 2023
Kim HM, Shin J.
europepmc   +1 more source

Seizure control with treatment of delayed sleep-wake phase disorder in juvenile myoclonic epilepsy: A case report. [PDF]

Epilepsy Behav Rep, 2023
Rehim E, Li SP, Vendrame M.
europepmc   +1 more source

Renal Denervation for Uncontrolled Hypertension: A Measurement-First, Program-Based Approach. [PDF]

J Clin Med
Szarpak L, Katipoglu B, Jaguszewski MJ, Baier A, Kubica J, Maslyk M, Pruc M, Momot K, Cander B, Lin Q.   +9 more
europepmc   +1 more source

Beyond Clozapine Failure: Precision Approach and Palliative Psychiatry in Ultra-Treatment-Resistant Schizophrenia. [PDF]

J Clin Med
Peraire M, Moreno-Beltrán A, Fillol A, Cabañés-Suñer M, Gimeno-Vergara R.   +4 more
europepmc   +1 more source

Renal denervation revisited: is patient selection the missing link between failure and success? [PDF]

Clin Hypertens
Shahverdi E, Herda LR, Manouchehri R, Shahi S, Lange M.   +4 more
europepmc   +1 more source